Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New compounds synthesized at Pfizer act as inhibitors of protein farnesyltransferase

Nov. 22, 2000

New series of thymidylate synthase inhibitors designed at Sunesis

Nov. 22, 2000

Novel nontaxane tubulin-polymerizing epothilone lactam discovered at BMS

Nov. 22, 2000

NCI-EORTC-AACR highlights: E-7070 progresses to phase II based on phase I findings

Nov. 22, 2000

No consistent PKC inhibition or significant MDR reversal in melanoma patients treated with CGP-41251

Nov. 22, 2000

Nonanticoagulant heparin derivative designed to exert antiangiogenic activity

Nov. 22, 2000

Novel nucleoside transport inhibitors may overcome limitations of dipyridamole

Nov. 22, 2000

First clinical trial results with Oxford Biomedica's MetXia reported

Nov. 22, 2000

Ligand's Targretin recommended for approval by CPMP

Nov. 22, 2000

Photogen Technologies' PH-10 shows promise for PDT in preclinical studies

Nov. 22, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...